Table 2.
Renal function parameters of participants with and without mitral annular calcifications (MAC), aortic annular calcifications (AAC) and aortic valve sclerosis (AVS)
| MAC | AAC | AVS | ||||
|---|---|---|---|---|---|---|
| No | Yes | No | Yes | No | Yes | |
| N = 2289 | N = 1640 | N = 2101 | N = 1710 | N = 1815 | N = 2114 | |
| eGFR | ||||||
| >60 mL/min/1.73 m2 | 59.5% | 40.5% | 56.3% | 43.7% | 46.6% | 53.4% |
| 45–60 mL/min/1.73 m2 | 57.9% | 42.1% | 54.0% | 46.0% | 45.1% | 54.9% |
| <45 mL/min/1.73 m2 | 43.9% | 56.1%* | 45.4% | 54.6%* | 40.7% | 59.3% |
| eGFR (mL/min/1.72 m2) | 70.2 ± 16.1 | 69.4 ± 17.5 | 70.2 ± 16.1 | 69.6 ± 17.3 | 70.0 ± 16.2 | 69.8 ± 17.1 |
| Cystatin C (mg/L) | 1.07 ± 0.25 | 1.12 ± 0.33* | 1.07 ± 0.25 | 1.11 ± 0.33* | 1.08 ± 0.26 | 1.09 ± 0.31 |
MAC, AAC and AVS were defined as present or absent, i.e. summing mild, moderate or severe versus none.
*P < 0.05.